Robert J. Decker - Mar 15, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Controller, CAO
Signature
Raavi K. Deol, as attorney-in-fact for Robert J. Decker
Stock symbol
JNJ
Transactions as of
Mar 15, 2022
Transactions value $
-$514,830
Form type
4
Date filed
3/17/2022, 04:30 PM
Previous filing
Feb 17, 2022
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $363K +5K +32.31% $72.54 20.5K Mar 15, 2022 Direct
transaction JNJ Common Stock Sale -$43.9K -250 -1.22% $175.51 20.2K Mar 15, 2022 Direct
transaction JNJ Common Stock Sale -$351K -2K -9.89% $175.51 18.2K Mar 15, 2022 Direct
transaction JNJ Common Stock Sale -$483K -2.75K -15.09% $175.51 15.5K Mar 15, 2022 Direct
holding JNJ Common Stock 562 Mar 15, 2022 By 401k F1
holding JNJ Common Stock 134 Mar 15, 2022 By ESOP F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -5K -37.14% $0.00 8.46K Mar 15, 2022 Common Stock 5K $72.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2022).
F2 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2022).